The effect of improvement of sarcopenia, frailty, and exercise tolerance by nutrition support for recovery phase cardiac rehabilitation.

The effect of improvement of sarcopenia, frailty, and exercise tolerance by nutrition support for recovery phase cardiac rehabilitation. - The effect of nutrition support

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033506

Enrollment

Registered

2018-07-31

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Group which intakes one nutrition support drink after each cardiac rehabilitation during 3 months Group which does not intake nutrition support drink

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who suffered from cardiovascular disease and has visited cardiac rehabilitation at least twice a week during recovery phase of cardiac rehabilitation and does not have an allergy of dairy product is included.

Exclusion criteria

Exclusion criteria: The patient who has an allergy of dairy product is excluded.

Design outcomes

Primary

Measure	Time frame
Exercise tolerance	—

Secondary

Measure	Time frame
lipid profile, BNP, NT-pro BNP, endothelial function by FMD, vascular function by PASESA and nico, physical activities, muscle volume, muscular strength, the rate of sarcopenia, frailty, and MACE	—

Countries

Japan

Contacts

Public ContactYasunori Suematsu

Fukuoka University Department of Cardiology

ysuematsu@fukuoka-u.ac.jp092-801-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026